
Join to View Full Profile
New Hampshire AveSilver Spring, MD 20904
Phone+1 240-402-4214
Barbara Ann (Prewitt) Scepura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Maryland, BaltimoreMasters, 2001
Publications & Presentations
PubMed
- 3 citationsFDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.Sonia Singh, Diana Bradford, Somak Chatterjee, Xiaoxue Li, Stephanie L Aungst
Clinical Cancer Research. 2025-04-14 - 2 citationsUS Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy.Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro
Journal of Clinical Oncology. 2024-09-01 - FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller
Clinical Cancer Research. 2024-08-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: